Compare JYNT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JYNT | EDAP |
|---|---|---|
| Founded | 2010 | 1979 |
| Country | United States | France |
| Employees | 330 | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.2M | 128.9M |
| IPO Year | 2014 | 1998 |
| Metric | JYNT | EDAP |
|---|---|---|
| Price | $8.32 | $4.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $17.00 | $10.00 |
| AVG Volume (30 Days) | ★ 76.0K | 44.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.93 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $117,696,356.00 | $70,527,000.00 |
| Revenue This Year | $12.23 | N/A |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | $91.44 | ★ N/A |
| Revenue Growth | ★ 15.49 | 1.63 |
| 52 Week Low | $7.50 | $1.21 |
| 52 Week High | $12.88 | $5.05 |
| Indicator | JYNT | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 61.10 |
| Support Level | $8.00 | $3.18 |
| Resistance Level | $8.77 | $4.38 |
| Average True Range (ATR) | 0.42 | 0.26 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 7.24 | 67.39 |
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.